论文信息 - Preliminary results of a prospective randomized study of basiliximab in kidney transplantation. - 字舞流文

Preliminary results of a prospective randomized study of basiliximab in kidney transplantation.

G. Iaria | G. Tisone | O. Buonomo | F. Pisani | A. Famulari | C. Casciani | V. Mazzarella | A. Piazza | M. Valeri | S. Pollicita | C. Camplone | Casciani Cu

[1] M. Hall,et al. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. , 1999, Transplantation.

[2] J. Kovarik,et al. Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts. , 1997, Transplantation.

[3] J. Soulillou,et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients , 1997, The Lancet.

[4] M. Schreier,et al. Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. , 1995, Transplantation.